Polysporin Ophthalmic Side Effects
Generic name: bacitracin / polymyxin b ophthalmic
Medically reviewed by Drugs.com. Last updated on Feb 24, 2021.
Note: This document contains side effect information about bacitracin / polymyxin b ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Polysporin Ophthalmic.
For the Consumer
Applies to bacitracin/polymyxin b ophthalmic: ophthalmic ointment
Side effects requiring immediate medical attention
Along with its needed effects, bacitracin/polymyxin b ophthalmic may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking bacitracin/polymyxin b ophthalmic:
Incidence not known
- Slow healing of the eye
Side effects not requiring immediate medical attention
Some side effects of bacitracin/polymyxin b ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence not known
- Burning, itching, redness, swelling, or irritation at the application site
For Healthcare Professionals
Applies to bacitracin / polymyxin b ophthalmic: ophthalmic ointment
Frequency not reported: Local irritation upon application[Ref]
Frequently asked questions
More about Polysporin Ophthalmic (bacitracin / polymyxin b ophthalmic)
Related treatment guides
1. "Product Information. Polysporin (bacitracin-polymyxin B ophthalmic)." Monarch Pharmaceuticals Inc, Bristol, TN.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.